1. Akaike Y, Arai Y, Taguchi H, Satoh H (1982) Effect of 1-(2-chloroethyl)-3-isobutyl-3-(?-maltosyl)-1-nitrosourea on experimental tumors. Gan 73:480
2. Anderson T, McMenamine M, Schein PS (1975) Chlorozotocin, 2-[3-(2-chloroethyl)-3-nitrosoureidol-d-glucopyranose, an antitumor agent with modified bone marrow toxicity. Cancer Res 35:761
3. Arai Y, Akaike Y, Seto M, Nakamura S, Satoh H (1980) Mode of action of 1-(2-chloroethyl)-3-isobutyl-3-(?-maltosyl)-1-nitrosourea (TA-077). Proc Japanese Cancer Assoc, 39th Annual Meeting, Tokyo, 735 (abstract)
4. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr (1977) Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas. Cancer 40:2660
5. Fujimoto S, Ogawa M, Hoshino A (1980) Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: Comparison with other antimetabolites. Gan 71:60